• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCSK9 缺陷型小鼠表现出葡萄糖耐量受损和胰岛异常。

PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities.

机构信息

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

出版信息

FEBS Lett. 2010 Feb 19;584(4):701-6. doi: 10.1016/j.febslet.2009.12.018. Epub 2009 Dec 16.

DOI:10.1016/j.febslet.2009.12.018
PMID:20026049
Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9), a liver-secreted plasma enzyme, restricts hepatic uptake of low-density lipoprotein (LDL) cholesterol by promoting the degradation of LDL receptors (LDLR). PCSK9 and LDLR are also expressed in insulin-producing pancreatic islet beta cells, possibly affecting the function of these cells. Here we show that, compared to control mice, PCSK9-null male mice over 4 months of age carried more LDLR and less insulin in their pancreas; they were hypoinsulinemic, hyperglycemic and glucose-intolerant; their islets exhibited signs of malformation, apoptosis and inflammation. Collectively, these observations suggest that PCSK9 may be necessary for the normal function of pancreatic islets.

摘要

前蛋白转化酶枯草溶菌素 9(PCSK9)是一种肝脏分泌的血浆酶,通过促进 LDL 受体(LDLR)的降解来限制肝脏对 LDL 胆固醇的摄取。PCSK9 和 LDLR 也在产生胰岛素的胰岛β细胞中表达,可能影响这些细胞的功能。在这里,我们发现与对照组小鼠相比,4 个月以上的 PCSK9 缺失雄性小鼠的胰腺中 LDLR 更多,而胰岛素更少;它们表现出低血糖、高血糖和葡萄糖不耐受;其胰岛出现了畸形、凋亡和炎症的迹象。综上所述,这些观察结果表明 PCSK9 可能是胰岛正常功能所必需的。

相似文献

1
PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities.PCSK9 缺陷型小鼠表现出葡萄糖耐量受损和胰岛异常。
FEBS Lett. 2010 Feb 19;584(4):701-6. doi: 10.1016/j.febslet.2009.12.018. Epub 2009 Dec 16.
2
Variable effects of gender and Western diet on lipid and glucose homeostasis in aged PCSK9-deficient C57BL/6 mice CSK9PC57BL/6.载脂蛋白 C3 基因敲除 C57BL/6 小鼠模型中性别和西方饮食对脂代谢和糖代谢的不同影响
J Diabetes. 2015 Jan;7(1):74-84. doi: 10.1111/1753-0407.12139. Epub 2014 Mar 27.
3
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis.胰腺 PCSK9 通过 LDLR-胆固醇轴控制β细胞分泌途径的组织。
Metabolism. 2022 Nov;136:155291. doi: 10.1016/j.metabol.2022.155291. Epub 2022 Aug 16.
4
Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9):肝细胞特异性低密度脂蛋白受体降解及在小鼠肝脏再生中的关键作用。
Hepatology. 2008 Aug;48(2):646-54. doi: 10.1002/hep.22354.
5
Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue.循环型前蛋白转化酶枯草溶菌素 9(PCSK9)调节内脏脂肪组织中 VLDLR 蛋白和甘油三酯的积累。
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):785-91. doi: 10.1161/ATVBAHA.110.220988. Epub 2011 Jan 27.
6
Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo.分泌型前蛋白转化酶枯草杆菌蛋白酶/kexin 9型在体内可减少肝脏和肝外低密度脂蛋白受体。
Biochem Biophys Res Commun. 2008 Jun 13;370(4):634-40. doi: 10.1016/j.bbrc.2008.04.004. Epub 2008 Apr 10.
7
PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion.PCSK9 在胰腺 δ 细胞中表达,不会改变胰岛素的分泌。
Biochem Biophys Res Commun. 2009 Dec 25;390(4):1288-93. doi: 10.1016/j.bbrc.2009.10.138. Epub 2009 Oct 28.
8
Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.禁食可在过表达前蛋白转化酶枯草溶菌素9型的小鼠中诱发高脂血症:低密度脂蛋白受体对极低密度脂蛋白肝脏输出缺乏调节作用。
Endocrinology. 2006 Oct;147(10):4985-95. doi: 10.1210/en.2006-0098. Epub 2006 Jun 22.
9
Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).白藜芦醇苷通过下调前蛋白转化酶枯草杆菌蛋白酶/九型酪蛋白激酶(PCSK9)改善2型糖尿病患者的脂质和葡萄糖代谢。
Cardiovasc Diabetol. 2016 Feb 1;15:19. doi: 10.1186/s12933-015-0325-x.
10
Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.腺病毒介导的小鼠体内前蛋白转化酶枯草溶菌素9(Pcsk9)表达导致低密度脂蛋白受体敲除表型。
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7100-5. doi: 10.1073/pnas.0402133101. Epub 2004 Apr 26.

引用本文的文献

1
Debate: Lipid-lowering Therapies and Diabetes Development.辩论:降脂疗法与糖尿病的发展
Curr Atheroscler Rep. 2025 Jan 8;27(1):24. doi: 10.1007/s11883-024-01270-y.
2
Successful use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report.前蛋白转化酶枯草溶菌素/克新9型抑制剂在高甘油三酯血症性急性胰腺炎中的成功应用:一例报告
Curr Cardiol Rev. 2025;21(3):116-120. doi: 10.2174/011573403X343784241115055037.
3
Genomic network analysis characterizes genetic architecture and identifies trait-specific biology.
基因组网络分析描绘了遗传结构并识别出特定性状的生物学特征。
medRxiv. 2024 Dec 5:2024.12.03.24318432. doi: 10.1101/2024.12.03.24318432.
4
Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights.多组学人类胰腺胰岛内质网和细胞因子应激反应图谱为 2 型糖尿病的遗传见解提供了依据。
Cell Metab. 2024 Nov 5;36(11):2468-2488.e7. doi: 10.1016/j.cmet.2024.09.006. Epub 2024 Oct 8.
5
Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations.肝外组织中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型缺乏症:新出现的考量因素
Front Pharmacol. 2024 Jul 30;15:1413123. doi: 10.3389/fphar.2024.1413123. eCollection 2024.
6
Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.原发性高脂血症与2型糖尿病之间的相互作用:治疗意义。
Diabetes Ther. 2024 Sep;15(9):1979-2000. doi: 10.1007/s13300-024-01626-2. Epub 2024 Jul 30.
7
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.脂质修饰干预的多效性:探索传统和新型降血脂疗法
Metabolites. 2024 Jul 17;14(7):388. doi: 10.3390/metabo14070388.
8
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.载脂蛋白 C-III 在心肾疾病中的作用及其调控机制
Diabetologia. 2024 Sep;67(9):1980-1997. doi: 10.1007/s00125-024-06191-8. Epub 2024 Jun 15.
9
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.靶向前蛋白转化酶枯草溶菌素 9(PCSK9):从实验室到临床。
Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3.
10
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.PCSK9 抑制剂对血糖控制和新发糖尿病的影响。
Cardiovasc Diabetol. 2024 Jan 3;23(1):4. doi: 10.1186/s12933-023-02077-y.